| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 College of Pharmacy, Pharmaceutics Division, University of Texas at Austin, Austin, Texas, USA; U.S. Army Institute of Surgical Research and Clinical Investigation, Brook Army Medical Center, San Antonio, Texas, USA
2 College of Pharmacy, Pharmaceutics Division, University of Texas at Austin, Austin, Texas, USA
3 U.S. Army Institute of Surgical Research and Clinical Investigation, Brook Army Medical Center, San Antonio, Texas, USA
* To whom correspondence should be addressed. E-mail: phillip.bowman{at}amedd.army.mil.
Interleukin-1 beta (IL-1
) and tumor necrosis factor alpha (TNF-
) are two major cytokines that rise to relatively high levels during systemic inflammation and the endothelial cell response to these cytokines may explain some of the dysfunction that occurs. To better understand the cytokine-induced responses of endothelial cells at gene expression level, human umbilical vein endothelial cells (HUVEC) were exposed to IL-1 or TNF- for various times and subjected to cDNA microarray analyses for the alterations of their mRNA expression. Of ~4,000 genes on the microarray, the expression levels of 33 genes appeared to be affected by IL-1 treatment and 58 by TNF-. Twenty-five of these genes responded to both treatments. These results suggest the effects of IL-1b and TNF- on endothelial cells are redundant and it may be necessary to suppress both at the same time to ameliorate the systemic response.
This article has been cited by other articles:
|
|
 |
|
  J. M. Kuldo, J. Westra, S. A. Asgeirsdottir, R. J. Kok, K. Oosterhuis, M. G. Rots, J. P. Schouten, P. C. Limburg, and G. Molema Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1229 - C1239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Akerstrom, A. Steensberg, P. Keller, C. Keller, M. Penkowa, and B. K. Pedersen Exercise induces interleukin-8 expression in human skeletal muscle J. Physiol., March 1, 2005; 563(2): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Krappmann, E. Wegener, Y. Sunami, M. Esen, A. Thiel, B. Mordmuller, and C. Scheidereit The I{kappa}B Kinase Complex and NF-{kappa}B Act as Master Regulators of Lipopolysaccharide-Induced Gene Expression and Control Subordinate Activation of AP-1 Mol. Cell. Biol., July 15, 2004; 24(14): 6488 - 6500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Luyendyk, W. B. Mattes, L. D. Burgoon, T. R. Zacharewski, J. F. Maddox, G. N. Cosma, P. E. Ganey, and R. A. Roth Gene Expression Analysis Points to Hemostasis in Livers of Rats Cotreated with Lipopolysaccharide and Ranitidine Toxicol. Sci., July 1, 2004; 80(1): 203 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mayer, M. Bilban, V. Kurtev, F. Gruber, O. Wagner, B. R. Binder, and R. de Martin Deciphering Regulatory Patterns of Inflammatory Gene Expression From Interleukin-1--Stimulated Human Endothelial Cells Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1192 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Viemann, M. Goebeler, S. Schmid, K. Klimmek, C. Sorg, S. Ludwig, and J. Roth Transcriptional profiling of IKK2/NF-{kappa}B-- and p38 MAP kinasedependent gene expression in TNF-{alpha}--stimulated primary human endothelial cells Blood, May 1, 2004; 103(9): 3365 - 3373. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
